U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07702656) titled 'A Phase II Clinical Trial Evaluating the Efficacy and Safety of SYS6026 Injection in Participants With HPV16 or 18-related High-grade Cervical Squamous Intraepithelial Lesions' on July 03.
Brief Summary: This trial is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the efficacy and safety of SYS6026 at different doses compared to placebo in treating patients with HPV16 or 18-related high-grade cervical squamous intraepithelial lesions (HSIL).
Study Start Date: July 10
Study Type: INTERVENTIONAL
Condition:
High-grade Cervical Intraepithelial Lesions
Intervention:
BIOLOGIC...